Medial septal GABAergic neurons express the somatostatin sst2A receptor: functional consequences on unit firing and hippocampal theta.
GABAergic septohippocampal neurons play a major role in the generation of hippocampal theta rhythm, but modulatory factors intervening in this function are poorly documented. The neuropeptide somatostatin (SST) may be one of these factors, because nearly all hippocampal GABAergic neurons projecting to the medial septum/diagonal band of Broca (MS-DB) express SST. In this study, we took advantage of the high and selective expression of the SST receptor sst2A in MS-DB to examine its possible role on theta-related activity. Immunohistochemical experiments demonstrated that sst2A receptors were selectively targeted to the somatodendritic domain of neurons expressing the GABAergic marker GAD67 but were not expressed by cholinergic neurons. In addition, a subpopulation of GABAergic septohippocampal projecting neurons expressing parvalbumin (PV) also displayed sst2A receptors. Using in vivo juxtacellular recording and labeling with neurobiotin, we showed that a number of bursting and nonbursting neurons exhibiting high discharge rates and brief spikes were immunoreactive for PV or GAD67 and expressed the sst2A receptor. Microiontophoresis applications of SST and the sst2A agonist octreotide (OCT) showed that sst2A receptor activation decreased the discharge rate of both nonbursting and bursting MS-DB neurons and lessened the rhythmic activity of the latter. Finally, intraseptal injections of OCT and SST in freely moving rats reduced the power of hippocampal EEG in the theta band. Together, these in vivo experiments suggest that SST action on MS-DB GABAergic neurons, through sst2A receptors, represents an important modulatory mechanism in the control of theta activity.
Bassant
Marie-Hélène
MH
Institut National de la Santé et de la Recherche Médicale, U549, Centre Paul Broca, F-75014 Paris, France.
Simon
Axelle
A
Poindessous-Jazat
Frédérique
F
Csaba
Zsolt
Z
Epelbaum
Jacques
J
Dournaud
Pascal
P
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D004569:Electroencephalography / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D007267:Injections; D007478:Iontophoresis; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D015282:Octreotide / Q000008:administration & dosage / Q000494:pharmacology; D010320:Parvalbumins / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D017481:Receptors, Somatostatin / Q000819:agonists / Q000187:drug effects / Q000502:physiology*; D012688:Septum Pellucidum / Q000166:cytology; D013004:Somatostatin / Q000008:administration & dosage / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D010320:Parvalbumins; D017481:Receptors, Somatostatin; C106140:somatostatin receptor sst2A; D013004:Somatostatin; D005680:gamma-Aminobutyric Acid; D015282:Octreotide
Neuroscience. 1999 Mar;89(3):909-26
10199624
Neuroscience. 1999 Mar;90(3):859-74
10218786
Neuroscience. 1999;92(2):589-600
10408608
J Comp Neurol. 1999 Sep 13;412(1):69-82
10440710
Exp Brain Res. 1999 Aug;127(3):244-58
10452212
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2376-82
10476805
Neuroscience. 1999;94(3):775-83
10579568
J Neurosci. 2000 Feb 1;20(3):1179-89
10648722
J Neurosci. 2000 May 15;20(10):3785-97
10804219
Neuroscience. 2000;98(4):661-8
10891609
J Neurophysiol. 2001 Apr;85(4):1709-18
11287493
Mol Cell Neurosci. 2001 Apr;17(4):646-61
11312601
Neuron. 2002 Jan 31;33(3):325-40
11832222
J Neurosci. 2002 Jul 1;22(13):5374-86
12097489
J Comp Neurol. 2002 Dec 9;454(2):192-9
12412143
J Physiol. 2003 Jan 1;546(Pt 1):101-17
12509482
Endocrinology. 2003 Apr;144(4):1564-73
12639941
Eur J Neurosci. 2003 May;17(9):1861-72
12752786
J Physiol. 2003 Sep 15;551(Pt 3):927-43
12865506
Brain Res. 2004 Apr 23;1006(1):74-86
15047026
J Neurosci. 2004 Apr 7;24(14):3527-36
15071100
Eur J Neurosci. 2004 Apr;19(8):2299-309
15090056
Eur J Neurosci. 2004 May;19(10):2753-68
15147309
Hippocampus. 2004;14(4):510-25
15224986
Eur J Neurosci. 2004 Oct;20(8):2149-58
15450094
J Neurosci. 2004 Sep 29;24(39):8470-9
15456820
Neuroscience. 1992;48(2):353-62
1603324
Neuroscience. 1991;42(2):451-62
1680227
Brain Res. 1989 Sep 18;497(2):315-24
2573406
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7518-21
2876428
Brain Res. 1989 Jan 30;478(2):375-81
2924136
Nature. 1988 Nov 10;336(6195):170-3
3185735
J Comp Neurol. 1985 Sep 8;239(2):237-46
4044938
Biophys J. 1967 Jul;7(4):391-418
4292791
Proc Natl Acad Sci U S A. 1982 May;79(10):3355-9
6124970
Neuroscience. 1984 Oct;13(2):265-339
6514182
Anat Embryol (Berl). 1984;169(1):41-4
6721220
J Neurosci. 1993 Sep;13(9):3712-24
7690065
Neuroscience. 1994 Oct;62(4):1033-47
7845584
J Neurosci. 1996 Jul 15;16(14):4468-78
8699257
J Neurosci Methods. 1996 Apr;65(2):113-36
8740589
J Physiol. 1996 Jul 1;494 ( Pt 1):201-15
8814616
J Neurosci. 1996 Oct 1;16(19):6000-11
8815883
Synapse. 1996 Jan;22(1):15-27
8822474
J Neurophysiol. 1996 Sep;76(3):1657-66
8890283
Neuroscience. 1997 Jan;76(1):225-40
8971774
J Physiol. 1997 Apr 15;500 ( Pt 2):463-74
9147330
Exp Brain Res. 1997 May;114(3):442-53
9187280
Brain Res Mol Brain Res. 1997 Oct 3;49(1-2):82-8
9387866
J Neurosci. 1998 Feb 1;18(3):1056-71
9437026
J Neurophysiol. 1998 Mar;79(3):1230-8
9497404
J Neurophysiol. 1998 Apr;79(4):1633-42
9535934
J Neurosci. 1998 Jul 1;18(13):4938-45
9634559
Neuron. 1998 Jul;21(1):9-12
9697847
Eur J Neurosci. 1998 Feb;10(2):464-77
9749709